Insider · CIK 0001802970
Durso-Bumpus Debra
Reports to the SEC for 1 company · CAMBRIDGE, MA
Transactions
50
Companies
1
Filings
4
CIK
0001802970
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpU Disposition from Tender | — |
| 2025-07-17 | Blueprint Medicines CorpD Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpA Award | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-07-17 | Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-03-05 | Blueprint Medicines CorpS Sale | −$458K |
| 2025-03-01 | Blueprint Medicines CorpStock Option (Right to Buy)A Award | — |
| 2025-03-01 | Blueprint Medicines CorpA Award | — |
| 2024-07-05 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-07-05 | Blueprint Medicines CorpM Exercise/Conversion | +$208K |
| 2024-07-05 | Blueprint Medicines CorpS Sale | −$428K |
| 2024-07-03 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-07-03 | Blueprint Medicines CorpS Sale | −$981K |
| 2024-07-03 | Blueprint Medicines CorpM Exercise/Conversion | +$477K |
| 2024-06-28 | Blueprint Medicines CorpM Exercise/Conversion | +$18K |
| 2024-06-28 | Blueprint Medicines CorpS Sale | −$37K |
| 2024-06-28 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-06-21 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-06-21 | Blueprint Medicines CorpM Exercise/Conversion | +$247K |
| 2024-06-21 | Blueprint Medicines CorpM Exercise/Conversion | +$127K |
| 2024-06-21 | Blueprint Medicines CorpM Exercise/Conversion | +$872K |
| 2024-06-21 | Blueprint Medicines CorpM Exercise/Conversion | +$839K |
| 2024-06-21 | Blueprint Medicines CorpS Sale | −$166K |
| 2024-06-21 | Blueprint Medicines CorpS Sale | −$1.97M |
| 2024-06-21 | Blueprint Medicines CorpS Sale | −$4.2M |
| 2024-06-21 | Blueprint Medicines CorpS Sale | −$1.35M |
| 2024-06-21 | Blueprint Medicines CorpS Sale | −$30.7K |
| 2024-06-21 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-06-21 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-06-21 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-07 | Blueprint Medicines CorpS Sale | −$462K |
| 2024-03-01 | Blueprint Medicines CorpA Award | — |
| 2024-03-01 | Blueprint Medicines CorpStock Option (Right to Buy)A Award | — |
| 2023-03-06 | Blueprint Medicines CorpS Sale | −$141K |
| 2023-03-06 | Blueprint Medicines CorpS Sale | −$3,278.2 |
| 2023-03-01 | Blueprint Medicines CorpStock Option (Right to Buy)A Award | — |
| 2023-03-01 | Blueprint Medicines CorpA Award | — |
| 2022-08-24 | Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-08-24 | Blueprint Medicines CorpM Exercise/Conversion | +$75.1K |
| 2022-08-24 | Blueprint Medicines CorpS Sale | −$376K |
| 2022-03-07 | Blueprint Medicines CorpS Sale | −$58.8K |
| 2022-03-03 | Blueprint Medicines CorpS Sale | −$89.9K |
| 2022-03-01 | Blueprint Medicines CorpStock Option (Right to Buy)A Award | — |
| 2022-03-01 | Blueprint Medicines CorpA Award | — |
Recent filings
- 4Durso-Bumpus Debra0001104659-25-069379SEC(opens sec.gov)
- 4Durso-Bumpus Debra0001415889-25-007381SEC(opens sec.gov)
- 4Durso-Bumpus Debra0001415889-25-006601SEC(opens sec.gov)
- 4Durso-Bumpus Debra0001415889-24-019331SEC(opens sec.gov)
Companies
Address
C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET
CAMBRIDGE, MA, 02139